GBIO

NASDAQ

Generation Bio Co.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2020

$5.37-0.35 (-6.20%)

News25/Ratings8

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Price$5.37+0.09 (+1.80%)

2025-11-032026-02-06

News · 26 weeks590%

2025-10-262026-04-19

Mix3790d

Insider16(43%)
SEC Filings13(35%)
Other5(14%)
Leadership2(5%)
Offering1(3%)

Latest news

25 items

64dSEC
SEC Form 15-12G filed by Generation Bio Co.
15-12G - Generation Bio Co. (0001733294) (Filer)
66dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Generation Bio Co.
SCHEDULE 13G/A - Generation Bio Co. (0001733294) (Subject)
71dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Generation Bio Co.
SCHEDULE 13G/A - Generation Bio Co. (0001733294) (Subject)
72dSEC
SEC Form EFFECT filed by Generation Bio Co.
EFFECT - Generation Bio Co. (0001733294) (Filer)
74dINSIDER
SEC Form 4 filed by Large owner Atlas Venture Fund X, L.P.
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Stehman-Breen Catherine closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
SEC Form 4 filed by Director Rhodes Jason P
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Rowland Charles A Jr closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Quinn Anthony G. closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Nicholson Donald William closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Mcdonough Geoff closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
SEC Form 4 filed by Director Jonas Jeffrey M
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
INTERIM CEO AND PRESIDENT Howze Yalonda closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
CHIEF FINANCIAL OFFICER Conway Kevin John closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Cooper Ronald Harold Wilfred closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Christensen Gustav closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dINSIDER
Director Appelhans Dannielle closing all direct ownership in the company (SEC Form 4)
4 - Generation Bio Co. (0001733294) (Issuer)
74dSEC
SEC Form POS AM filed by Generation Bio Co.
POS AM - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)
74dSEC
SEC Form S-8 POS filed by Generation Bio Co.
S-8 POS - Generation Bio Co. (0001733294) (Filer)